Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?
- 1 June 2014
- journal article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 14 (6), 527-532
- https://doi.org/10.1016/s1473-3099(13)70360-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosisBMC Infectious Diseases, 2013
- Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trialPublished by Elsevier BV ,2013
- Point‐of‐care diagnosis of tuberculosis: Past, present and futureRespirology, 2013
- Xpert (R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)Published by Wiley ,2012
- Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysisEuropean Respiratory Journal, 2012
- Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative Pulmonary Tuberculosis in a HIV Prevalent SettingPLOS ONE, 2012
- Performance of the new WHO diagnostic algorithm for smear‐negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in UgandaTropical Medicine & International Health, 2012
- Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patientsEuropean Respiratory Journal, 2012
- Performance of an algorithm based on WHO recommendations for the diagnosis of smear‐negative pulmonary tuberculosis in patients without HIV infectionTropical Medicine & International Health, 2011
- Reducing the global burden of tuberculosis: the contribution of improved diagnosticsNature, 2006